Activin A in Mammalian Physiology

• Published in: Physiological reviews Vol. 99; no. 1; pp. 739 - 780
• Main Authors: Bloise, Enrrico, Ciarmela, Pasquapina, Dela Cruz, Cynthia, Luisi, Stefano, Petraglia, Felice, Reis, Fernando M
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.01.2019
• Subjects: Activin; Antagonists; Bone growth; Embryos; Fetuses; Follicle-stimulating hormone; Follicular fluid; Glycoproteins; Growth factors; Hypoxia; Liver; Osteogenesis; Physiology; Pituitary; Pregnancy; Regeneration; Reproductive organs; Reproductive system; Respiratory system; Rheumatoid arthritis; Transforming growth factor-b; Uterus
• ISSN: 0031-9333; 1522-1210
• DOI: 10.1152/physrev.00002.2018

Activins are dimeric glycoproteins belonging to the transforming growth factor beta superfamily and resulting from the assembly of two beta subunits, which may also be combined with alpha subunits to form inhibins. Activins were discovered in 1986 following the isolation of inhibins from porcine follicular fluid, and were characterized as ovarian hormones that stimulate follicle stimulating hormone (FSH) release by the pituitary gland. In particular, activin A was shown to be the isoform of greater physiological importance in humans. The current understanding of activin A surpasses the reproductive system and allows its classification as a hormone, a growth factor, and a cytokine. In more than 30 yr of intense research, activin A was localized in female and male reproductive organs but also in other organs and systems as diverse as the brain, liver, lung, bone, and gut. Moreover, its roles include embryonic differentiation, trophoblast invasion of the uterine wall in early pregnancy, and fetal/neonate brain protection in hypoxic conditions. It is now recognized that activin A overexpression may be either cytostatic or mitogenic, depending on the cell type, with important implications for tumor biology. Activin A also regulates bone formation and regeneration, enhances joint inflammation in rheumatoid arthritis, and triggers pathogenic mechanisms in the respiratory system. In this 30-yr review, we analyze the evidence for physiological roles of activin A and the potential use of activin agonists and antagonists as therapeutic agents.